The Valley Desk

ArticleHeart rhythmPublished

Mavacamten-like myosin inhibitor MYK-581 reduces the risk of atrial fibrillation induction in a murine model of hypertrophic cardiomyopathy

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

Publication record

Type
Article
Venue
Heart rhythm
Published
Subject terms
Atrial fibrillation; hypertrophic cardiomyopathy; Mouse Models; Atrial Cardiomyocytes; Myosin Inhibitor
PubMed ID
41707765
Added to directory
Source checked

Report a correction or request removal